MSB trading, page-2046

I totally agreed with you Vinn!

Felt to me the invisible force that has been controlling MSB's SH all these years has revealed itself so prominently in past 2 weeks and left a lot of shadows for us to see ...…..

Soaring from $1.6 about 2 weeks ago and stop briefly at resistance level of around $2.33-$2.35, before news of end stage CHF trial result presentation at AHA conference on Wednesday morning caused SP to spike to just below next resistance level of $2.5, followed by a correction of 50% of all recent gain to close Wednesday @$2; The invisible hands did not want everyone to think its another pump & dump exercise and allow SH to climb back & close at $2.2 on Thursday. Today is less dramatic and a controlled finish of $2.1 (price that a number of institutions bought in some years ago?) dampened the enthusiasm of some day-traders.

Too textbook, too scripted for me! I let our fellow HC posters speculate what's the motive behind these dark forces. But I happily pick up another small parcel today. (*Note: not an investment advice. MSB is still a highly speculative stock!)

I bought not because I thought these invisible hands were doing their last leg of accumulation. I increase my investment in MSB because I am very confident the November Presentation will change the way end stage cardiac patients be treated in future, and MSB's platform of modalities will be vindicated in public views of cardiologist/thoracic surgeons worldwide, as this trial is sponsored by US's NIH and Canadian Institute for Health Research , and conducted by CTSN. Critics can no longer tarnish any good results by innuendo of MSB's data mining.

Does anyone know who will be presenting on stage that day?
Will it be the Harvard Cardiology Professor? the Canadian Top Cardiac Surgeon?
academics from NY's Icahn School of Medicine? or should it be left to Silvu to carry our Australian flag?


Cheers!
S.O.M.